New SEC Form D filing

Aer Therapeutics, Inc., 2026-08-19

A new SEC Form D private-offering notice from Research Triangle Park, NC, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Aer Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing fexlamose, a mucolytic drug candidate for COPD, asthma and other mucus obstructive lung diseases

New filing todayFiled to raise $3,000,000First money in 2026-08-07Raised so far $3,000,000HQ (as filed) Research Triangle Park, NCSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aertherapeutics.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in North Carolina →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source